Publication | Closed Access
Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients
70
Citations
19
References
2006
Year
Our results suggest the potential for the three-dose schedule of recombinant vaccine Engerix-B 80 microg to prolong the immune response among ESRD population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1